Skip to main content

Table 1 Demographic data of the 19 patients with primary (P) or recurrent (R) ovarian cancer and peritoneal carcinomatosis

From: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

No. Age Ovarian cancer Initial FIGO tumor stage Previous chemotherapy Progression-free (months)
1 65 P III None 0
2 53 R III Platinum derivatives 18
3 60 P III None 0
4 63 P III None 0
5 54 R III Platinum derivatives 12
6 36 R IV Platinum derivatives 9
7 54 R III Platinum derivatives 6
8 44 P IV None 0
9 56 P III None 0
10 43 P III None 0
11 53 R IV Taxanes 9
12 61 P IV Taxanes and Platinum derivatives 0
13 42 R IV Taxanes and platinum derivatives 30
14 50 R III Platinum derivatives 36
15 59 R III Platinum derivatives 18
16 79 R III None 19
17 30 P III None 0
18 58 R III Platinum derivatives 12
19 73 R III Platinum derivatives 18